The presence of high-grade prostatic intraepithelial neoplasia (HG-PIN) or atypical small acinar proliferation (ASAP) in biopsy specimens does not appear to affect risk for upstaging or upgrading among men who are otherwise good candidates for active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: acinar, active surveillance, ASAP, atypia, HG-PIN, intraepithelial, neplasia, outcome, proliferation, risk | Leave a comment »
It has long been understood that a finding of “atypia” (atypical small acinar proliferation) on an initial biopsy of the prostate is associated with an increased risk for prostate cancer, and a repeat biopsy is normally recommended for any patient with an initial finding of atypia. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: acinar proliferation, ASAP, atypia, biopsy, follow-up | 3 Comments »
Today’s news reports address issues such as:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: atypia, detection, markers, pathology, pro-PSA, risk, testosterone therapy | Leave a comment »
Newly published studies today include data on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation, antiandrogen, atypia, bicalutamide, brachytherapy, cancer, depression, fatigue, flutamide, irritability, mood, prostate, quality of life, radiotherapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 